Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Florence

Baron-Papillon

President (Sanofi)

To Be

Confirmed

Vice-President

Andreas

Potthoff

(Abbott)

Hugo

Gomes da Silva

(AstraZeneca)

Sharon

McHale

(CSL Seqirus)

Sue

Middleton

(GSK)

Jürgen

Betzing

(IDT Biologika)

Jurgen

Kwik

(Janssen/JnJ)

John

Lepore

(Moderna)

Nicoletta

Luppi

(MSD)

Kelly

Cappio

(Novavax)

Marc

Dreiner

Treasurer (Pfizer)

Logan

Rae

(Takeda)

Juan Carlos

Jamarillo

(Valneva)

Executive office

Sibilia

Quilici

Executive Director

Laurent

Louette

Director Public Affairs & Country Liaison

Anna

Czwarno

Director, Regulatory and R&D

Anna

Vicere

Senior Manager, Access Policy & Public Affairs

Polina

Zoteva

Communications Lead

Anne

Meynaerts

Administrative Assistant

Working Group Chairs

Research, Innovation & Medical

Manufacturing & Supply

Philippe

Juvin

Sanofi

National Vaccine Industry Group's Task Force

Renée

Gallo-Daniel

Pfizer